Join the Colorectal Cancer group to help and get support from people like you.
Colorectal Cancer News (Page 7)
Related terms: Cancer, Anal, Cancer, Colon, Cancer, Colorectal, Cancer, Rectal, Colon Cancer, Colon Carcinoma, Colorectal Carcinoma, Rectal Cancer
Locally Recurrent Rectal Cancer QoL Is Valid Patient-Reported Outcome Measure
FRIDAY, June 9, 2023 – A new locally recurrent rectal cancer (LRRC) quality of life (QoL) measure is a valid patient-reported outcome measure (PROM), according to a study published in the May issue...
ASCO: Germline Testing Underused in Cancer Patients
TUESDAY, June 6, 2023 – Few patients diagnosed with cancer between 2013 and 2019 in California and Georgia underwent germline testing, according to a study published online June 5 in the Journal of...
High Visualization Found With Magnetically Controlled Capsule Endoscopy
MONDAY, June 5, 2023 – Magnetically controlled capsule endoscopy (MCCE) offers a high rate of visualization of all regions of the gastric mucosa and is associated with high patient satisfaction and...
Men: Here Are the Health Screenings You Need
MONDAY, June 5, 2023 – Many men will put off going to the doctor unless they are really sick, but men's health screenings help catch problems before symptoms appear. So, how can you tell if a health...
ASCO: Microbiome Varies for Early-Onset, Late-Onset Colorectal Cancer
FRIDAY, June 2, 2023 – The microbiome (MB) of patients with colorectal cancer (CRC) varies between those diagnosed with early- or late-onset disease, according to a study presented at the annual...
Could Microbiome Changes Explain Rise in Colon Cancer Among the Young?
FRIDAY, May 26, 2023 – With colon cancer on the rise among younger Americans, researchers are working to figure out why. A new study suggests the microbiome — the community of microorganisms in the b...
Red-Flag Signs May Indicate Early-Onset Colorectal Cancer
WEDNESDAY, May 24, 2023 – Four red-flag signs and symptoms may signal an elevated risk for early-onset colorectal cancer (CRC), according to a study published online May 4 in the Journal of the...
9-Minute Withdrawal Time Cuts Adenoma Miss Rate in Colonoscopy
TUESDAY, May 23, 2023 – A 9-minute mean withdrawal time (m-WT) for screening colonoscopy significantly reduces the adenoma miss rate (AMR) and advanced adenoma miss rate (AAMR), in addition to...
The Women’s Health Screenings and Preventive Care Appointments You Need
FRIDAY, May 19, 2023 – Health screenings and preventive care appointments are a key to maintaining long-term health and well-being. By proactively engaging in these practices, women can identify...
1996 to 2020 Saw Cancer Death Rates Drop Across Congressional Districts
TUESDAY, May 16, 2023 – From 1996-2003 to 2012-2020, there was a decrease in cancer death rates in all congressional districts, according to a study published online May 9 in Cancer. Farhad Islami,...
More Evidence That Obesity Raises Odds for Gastrointestinal Cancers
FRIDAY, May 12, 2023 – Maintaining a healthy weight may be important for reducing the risk of gastrointestinal cancer, a new study suggests. The research adds to the evidence that excess weight and...
Overweight, Obesity in Early, Middle Adulthood Increases Risk for GI Cancers
THURSDAY, May 11, 2023 – Overweight and obese body mass indices (BMIs) in early and middle adulthood are associated with a higher risk for colorectal cancer (CRC) and non-CRC gastrointestinal (GI)...
Four Signs That a Young Adult Might Have Colon Cancer
FRIDAY, May 5, 2023 – Four symptoms could provide early warning of colon cancer in younger adults. Being aware of these red flags could lead to earlier detection and diagnosis for those under age...
FTD-TPI Plus Bevacizumab Increases Survival in Refractory Advanced CRC
THURSDAY, May 4, 2023 – Treatment with trifluridine-tipiracil (FTD-TPI) plus bevacizumab yields longer overall survival than FTD-TPI alone among patients with refractory metastatic colorectal...
Seagen Announces FDA Accelerated Approval of Tukysa (tucatinib) in Combination with Trastuzumab for People with Previously Treated RAS Wild-Type, HER2-Positive Metastatic Colorectal Cancer
BOTHELL, Wash.--(BUSINESS WIRE) January 19, 2023 – Seagen Inc. (Nasdaq: SGEN) today announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval to Tukysa (tucatinib)...
Ask a question
To post your own question to this support group, sign in or create an account.